A Deep Dive into Adult Vaccines Market 2025: Key Drivers, Growth Factors, and Projections 2025-2034

"How Are the key drivers contributing to the expansion of the adult vaccines market?
The escalating occurrence of highly infectious diseases is propelling the advancement of the adult vaccine market. These are diseases that transmit from one person to another. Vaccinations assist an individual in building resistance against such diseases, making these an efficient tool in combating infections. As an example, per the data released by the Centers for Disease Control and Prevention - a US-based national public health organization, in March 2023, 8,300 instances of tuberculosis were reported in the United States in 2022, higher than the 7,874 cases registered in 2021. The prevalence of TB in 2022 saw a slight rise to 2.5 per 100,000 individuals from 2.4 the previous year. Owing to these factors, the escalating prevalence of infectious diseases is facilitating the growth of the adult vaccine market.

Get Your Adult Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

What growth opportunities are expected to drive the adult vaccines market's CAGR through 2034?
The market size of adult vaccines has seen solid growth in the past few years. It is projected to rise from $22.82 billion in 2024 to $24.49 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.3%. The growth during the historic period was largely driven by factors such as an increasing older population, government-run vaccination initiatives, heightened awareness about preventative healthcare, advancements and innovation in vaccine development, and public health awareness campaigns.

The size of the adult vaccine market is looking towards a robust increase in the upcoming years, potentially reaching a value of $35.22 billion by 2029 with a compound annual growth rate (CAGR) of 9.5%. The reasons for this projected rise during the prediction span can be accredited to the development of novel infectious risks, heightened attention towards immunization lists, the growing problem of antimicrobial resistance, worldwide initiatives for dealing with pandemics, a shift in preference for personalized vaccines, and an increased emphasis on maternal immunization. Notable trends expected during this period comprise the integration of digital health, advancements in vaccine creation technology, partnerships between governmental bodies and pharmaceutical corporations, improvements in vaccine distribution methods, and wider-reaching immunization campaigns.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What are the emerging trends shaping the future of the adult vaccines market?
The introduction of innovative products is a major trend that is emerging in the adult vaccines market, with leading companies launching new products to maintain their market standing. For example, in August 2022, GSK, a biopharma company based in the UK, partnered with IQVIA, a global leader in advanced analytics, technology solutions, and clinical research services from India, to introduce Vaccine Track. This data trend platform aims to boost adult vaccination in communities across the country by offering regular and pertinent data on trends to bolster public health initiatives.

Which growth-oriented segments of the adult vaccines market are leading the industry's development?
The adult vaccines market covered in this report is segmented -

1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals

Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

What regions are leading the charge in the adult vaccines market?
North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the adult vaccines market?
Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Is Covered In The Adult Vaccines Global Market Report?

• Market Size Forecast: Examine the adult vaccines market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the adult vaccines market for a structured understanding.
• Key Players Overview: Analyze major players in the adult vaccines market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the adult vaccines market.
• Segment Contributions: Evaluate how different segments drive overall growth in the adult vaccines market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the adult vaccines market.
• Industry Challenges: Identify potential risks and obstacles affecting the adult vaccines market.
• Competitive Landscape: Review strategic developments in the adult vaccines market, including expansions, agreements, and new product launches.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.